It is known that type I IFNs induce upregulation of PD-L1 resulting in expression of PD-L1 on tumor cells and immune cells [11, 31, 32], making them more susceptible to IFN activity by PD-L1-targeted AFN, as such creating a feed-forward loop. The gene discussed is IFNA1; the disease is neoplasm.